Background: Neurotransmitters, including substance P (SP) and neurokinin A (NKA),
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To the Editor:
Asthma, an inflammatory disease of the airways, is associated with various Th and innate immune cells. 1 Pulmonary disorders with chronic inflammation induced by infections and severe asthma, including childhood asthma and chronic obstructive pulmonary disease in smokers, are major public health issues. Hypersensitivity pneumonitis (HP) is a complex pulmonary disease caused by repeated exposure to allergens and irritants. 2 The precise mechanisms mediating severe asthma and HP have remained to be elucidated.
Neurotransmitters including substance P (SP) and neurokinin A (NKA) are widely distributed in both the central and peripheral nervous system and their receptors, neurokinin-1 receptor (NK1R) and neurokinin-2 receptor (NK2R), are expressed on immune cells. However, the role of the NKA-NK2R axis in immune responses relative to the SP-NK1R signaling cascade has not been elucidated. Previously, we demonstrated that neuropeptide signaling through NK2R was correlated with airway hyperresponsiveness in mouse severe asthma models. 3 Moreover, we found that the NKA-NK2R signaling pathway was involved in the antigen-presenting function of murine dendritic cells (DCs) and that NK2R expression on DCs was enhanced by Ohtake 8
IFN- and LPS stimulation in a STAT-1-dependent manner. 4 Additionally, we confirmed that human DCs significantly upregulated gene expression levels of NK2R and TAC-1, which encoded Substance P and Neurokinin A, after IFN- or poly I:C stimulation, suggesting possible roles of neuropeptide signaling in human DCs. 4 In this study, we investigated the effects of neuropeptide signaling through NK2R as well as NK1R on antigen presentation by human DCs and the subsequent activation of effector Th cells.
Human DCs (MoDCs), generated from peripheral blood mononuclear cells (PBMCs) in the presence of GM-CSF plus IL-4, demonstrated increased NK2R and NK1R expression after IFN-, IFN- LPS or poly I:C stimulation (Fig. 1, A and B) . The upregulation by poly I:C stimulation were convincing, whereas effects of IFNs were modest. In this study, we found that poly I:C-stimulated MoDCs also induced IFN- and IFN- production (see Fig. E1A in the Online Repository). Upregulation of NK1R and NK2R gene expression by poly I:C was STAT-1 dependent (Fig. 1, C) . We confirmed that surface expression levels of NK1R and NK2R on MoDCs were significantly enhanced by poly I:C stimulation (Fig. 1, D) . Additionally, we found that both NK2R and NK1R were expressed on CD68 or CD163 positive macrophages and To further evaluate whether neuropeptide signaling through NK1R and NK2R
were related to poly I:C-induced DC maturation, we analyzed the surface expression levels of HLA and costimulatory molecules following treatment with an NK1R or NK2R
antagonist. HLA-DR, CD80, CD86, and CD40, but not HLA-A/B/C and CCR7 expressions, upregulated by poly I:C stimulation through STAT1 activation (see Fig.   E1B in the Online Repository), were attenuated in the presence of an NK1R or NK2R antagonist ( Fig. 2, A) . In this experiment, we confirmed that these antagonists did not increase 7AAD + and/or Annexin + cells after the treatments. We further confirmed that Substance P (25.2 ± 9.2 pg/mL) and Neurokinin A (44.6 ± 27.5 pg/mL) were produced in the culture supernatants of MoDCs (2.5×10 5 cells) for 24 h and HLA-class II expression levels on these neuropeptide-treated MoDCs were suppressed in the presence of these antagonists (see Fig. E3 in the Online Repository). Thus, To confirm the effect of NK2R-mediated signaling on DC antigen presentation, we induced Bet-v1-specific IFN--or IL-4-producing Th cells in vitro using birch-derived antigen (see Fig. E4 in the Online Repository), as described previously. 5, 6 T-cell proliferation and cytokine production was evaluated after stimulation with antigen-loaded MoDCs. Blocking NK2R-mediated signaling suppressed the induction of antigen-specific CD4 + T cells (Fig. 2, B) . Furthermore, MoDC IL-12 production, as detected by ELISA in culture supernatants, was reduced in the presence of NK2R or NK1R antagonists (Fig. 2, C) .
Previous reports demonstrated that DC-T-cell interactions through CD40-CD40L
Ohtake 11
binding induces IL-12 production by DCs. 7 It has also been shown that SP-NK1R signaling activates IL-12 secretion by DCs. Neuropeptides, such as SP and NKA, act mainly through their receptors, NK1R
and NK2R, respectively, which may also be novel therapeutic targets in asthma.
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Previous studies demonstrated that antagonism of NK1R and NK2R by receptor antagonists reduced airway hyperresponsiveness (AHR) and improved lung function. 9 However, the clinical effects on airway inflammation and asthma symptoms are poorly understood. Recently, we found that human DCs upregulated the expression of TAC-1, which encodes SP and NKA, after IFN- or poly I:C stimulation. 6 Thus, we speculated that type 1 immune-dominant severe asthma, which may be caused by viral infections, will be a promising target for therapy using NK1R and NK2R antagonists.
We conclude that neuropeptide signaling through NK2R and NK1R promotes both innate and acquired immune responses through DC activation, suggesting that neuro-immune crosstalk may be associated with various diseases, including infection and chronic inflammation such as severe asthma and HP.
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Quantification of gene expression
Total RNA was extracted from human MoDCs using an RNeasy kit (QIAGEN, Hilden, Germany). First-strand cDNAs were synthesized using oligo (dT) primers (Life Technologies) with Superscript III reverse transcriptase (RT; Life Technologies).
Genes for human NK1R (TACR1), NK2R (TACR2), IFN-α (IFNA), IFN-β (IFNB),
IL-12p35 (IL12A), and GAPDH (GAPDH) were amplified by thermal cycler (LightCycler, Roche, F. Hoffmann-La Roche AG, Basel, Switzerland) with specific primers (see Table E2 in the Online Repository). Sample signals were normalized to GAPDH according to the ∆∆Ct method: ∆Ct = ∆Ct sample -∆Ct reference . Gene expression relative to the control sample was then calculated for each sample. In some experiments, NK1R, NK2R and GAPDH were amplified by thermal cycling using a GeneAmp PCR System 9700 (Life Technologies). Protein expression was visualized using EnVision (Dako ChemMate) for NK1R or N-Histofine Simple Stain MAX PO(G) (Nichirei Biosciences, Inc., Tokyo, Japan), followed by DAB using an Autostainer Plus System (DAKO ChemMate).
Immunofluorescence staining
Dual-color immunofluorescence staining was performed for lung tissues of patients with asthma or HP. The sections were incubated with primary antibodies for (M0814, at 1:300 dilution, Dako ChemMate), CD163 (NCL-CD163, 1:300 dilution, 
Enzyme immunoassay
Human MoDCs were generated from PBMCs of healthy donors (N=4) and the culture medium was freshly changed. Substance P and Neurokinin A production levels in culture supernatants of MoDCs (2.5×10 5 cells) for 24 h were determined using EIA kits (Substance P: Phoenix Pharmaceuticals, Inc., Burlingame, CA, USA, Neurokinin A: Peninsula Laboratories, San Carlos, CA, USA) according to the manufacture's protocols. Mean and SD of the Substance P and Neurokinin A production levels were calculated, respectively. antagonists. White birch antigen-specific CD4 + T cells were stimulated by Bet-v1
Induction of Bet-v1-specific Th cells
peptide-pulsed MoDCs in the presence of NK1R and NK2R antagonists for 24 h. IL-2
and IL-4 production levels in the culture supernatants were evaluated by ELISA.
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Representative mean and SD of cytokine levels are shown. 
